While underreported, ADR data offers significant value to the drug development value chain to refine the predictive capability and stability, and provide enhanced patient safety.
Philipp Hofmann, MD
Advertisement
Director, Pharmacovigilance & QPPV, Navitas Life Sciences
Articles by Philipp Hofmann, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Continuous Glucose Monitoring in Diabetes Clinical Trials: Endpoints, Regulatory Guidance, and Operational Best Practices
2
What Smaller Biotechs Need to Get Right in Their First APAC Phase III Trial
3
Why So Many Patients From Underrepresented Groups Are Never Asked to Join a Trial
4
Why APAC Clinical Trial Sites Deserve a Second Look: Q&A with James Cheong, Precision for Medicine
5